Astrana Health, Inc.
NASDAQ:ASTHMedical - Care Facilities
+$1.03 today
- Market cap
- $1.47B
- Beta
- 0.94
- P/E (TTM)
- 63.3
- EPS (TTM)
- $0.62
Volume 0.52M
Average 0.51M
ASTH Total Liabilities
Everything the company owes to creditors and other parties.
Astrana Health, Inc.NASDAQ: ASTH
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities rises 119.0% from a year ago
Total liabilities stood at $1.78B at the end of Q1 FY2026, up 119.0% from a year earlier and up 7.3% from the prior quarter. Over 3 fiscal years it compounded at +59.7% a year.
Context
- Total liabilities amounted to 75.5% of total assets at the end of Q1 FY2026, up 14.4 pp from a year earlier.
- Total liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +119.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 1.66B USD
- Year-over-year change
- +97.5%
- 4-year CAGR
- +46.9%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.66B | +97.5% |
| FY2024 | 2024-12-31 | 840.73M | +60.9% |
| FY2023 | 2023-12-31 | 522.59M | +28.2% |
| FY2022 | 2022-12-31 | 407.67M | +14.3% |
| FY2021 | 2021-12-31 | 356.72M | — |
Total Liabilities vs competitors
How ASTH compares with its peers on the latest reported figures
- ASTH's Mar 2026 total liabilities of $1.78B is the highest of the 4 companies compared; the peer median is $650.51M.
- Its year-over-year change of +119.0% is the highest of 4, against a peer median of +5.8%.
- Total liabilities amounts to 75.5% of total assets for ASTH, versus a peer median of 53.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $1.78B | +119.0% | +59.7% | 75.5% | |
| Mar 2026 | $1.32B | -7.6% | +20.3% | 87.9% | |
| Jun 2026 | $650.51M | +20.7% | +28.3% | 43.7% | |
| Mar 2026 | $515.27M | +5.8% | +16.7% | 53.8% | |
| Peer median (excluding ASTH) | $650.51M | +5.8% | +20.3% | 53.8% | |
Competitors are the stored peer set for ASTH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 233.1M | 288.03M | 293.81M | 288.46M | 429.47M |
| Short-term Investments | 53.42M | 5.57M | 2.5M | 2.38M | 0 |
| Net Receivables | 99.31M | 119.73M | 147.75M | 324.8M | 407.58M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 14.8M | 17.45M | 22.86M | 26.26M |
| Total Current Assets | 404.46M | 428.13M | 461.51M | 638.5M | 863.31M |
| Property, Plant & Equipment (Net) | 68.63M | 128.98M | 44.57M | 46.88M | 94.43M |
| Goodwill | 246.42M | 269.05M | 278.83M | 419.25M | 863.94M |
| Intangible Assets | 82.81M | 76.86M | 71.65M | 118.18M | 270.97M |
| Long-term Investments | 42.61M | 42.7M | 32.17M | 48.22M | 25.64M |
| Tax Assets | 0 | 15.94M | 42.42M | 20.66M | 0 |
| Other Non-current Assets | 22.44M | 4.56M | 2.22M | 63.22M | 100.37M |
| Total Non-current Assets | 462.9M | 538.09M | 471.85M | 716.4M | 1.36B |
| Total Assets | 867.36M | 966.21M | 933.36M | 1.35B | 2.22B |
| Account Payables | 5.51M | 10.47M | 9.08M | 15.17M | 44.84M |
| Short-term Debt | 780K | 619K | 19.5M | 9.38M | 55.67M |
| Tax Payables | 0 | 4.28M | 0 | 11.04M | 0 |
| Deferred Revenue | 16.8M | 531K | 744K | 1.61M | 2.66M |
| Other Current Liabilities | 65.89M | 113.24M | 164M | 257.74M | 480.48M |
| Total Current Liabilities | 114.72M | 148.61M | 218.67M | 365.61M | 615.27M |
| Long-term Debt | 182.92M | 203.39M | 258.94M | 425.3M | 990.9M |
| Deferred Tax Liabilities | 30.14M | 14.22M | 4.07M | 4.56M | 5.49M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 14.78M | 20.26M | 3.59M | 14M | 17.11M |
| Total Non-current Liabilities | 242M | 259.06M | 303.92M | 475.12M | 1.05B |
| Total Liabilities | 356.72M | 407.67M | 522.59M | 840.73M | 1.66B |
| Common Stock | 45K | 47K | 47K | 48K | 49K |
| Retained Earnings | 137.25M | 182.42M | 243.13M | 286.28M | 308.38M |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 62.48M | 15.99M | (203.45M) | (198.55M) | (220.96M) |
| Total Equity | 510.64M | 558.55M | 410.77M | 514.17M | 558.33M |
| Total Debt | 200.98M | 229.36M | 321.01M | 471.84M | 1.08B |
| Net Debt | (32.11M) | (58.66M) | 27.21M | 183.38M | 648.66M |
Astrana Health, Inc.
NASDAQ:ASTH
Intrinsic Alpha fair value
Locked
Current Price
$29.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.